Torrent Pharmaceuticals is expanding its voluntary recall for tablets used to control hypertension in the US due to detection of traces of N-Methylnitrosobutyric acid. The company is expanding recall for Losartan potassium tablets USP and Losartan potassium / hydrochlorothiazide tablets to the consumer level due to the detection of trace amounts of an unexpected impurity detected while testing some finished product batches manufactured utilising active pharmaceutical ingredient manufactured by Hetero Labs.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
